JPH09508264A - 哺乳類単球化学誘引物質タンパク質レセプター - Google Patents
哺乳類単球化学誘引物質タンパク質レセプターInfo
- Publication number
- JPH09508264A JPH09508264A JP7519133A JP51913395A JPH09508264A JP H09508264 A JPH09508264 A JP H09508264A JP 7519133 A JP7519133 A JP 7519133A JP 51913395 A JP51913395 A JP 51913395A JP H09508264 A JPH09508264 A JP H09508264A
- Authority
- JP
- Japan
- Prior art keywords
- mcp
- receptor
- sequence
- cells
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.MCP−1Rの発現をコードする、単離DNA配列。 2.他のポリペプチドと会合せず、かつ図1(配列番号:2)又は図2(配列 番号:4)の成熟アミノ酸配列を含む、ポリペプチド。 3.他のポリペプチドと会合していないポリペプチドであって、 i)図1(配列番号:1)又は図2(配列番号:3)のDNA配列、 ii)厳格な条件下でi)のDNAにハイブリダイズ可能なDNA、及び iii)遺伝暗号の縮重によってコード配列がi)及びii)のDNAとは 異なるDNA、 から成る群から選択されるDNA配列でコードされる、ポリペプチド。 4.前記単離DNAがcDNAを含む、請求の範囲第1項に記載のDNA。 5.請求の範囲第1項のDNA配列を含む発現ベクター。 6.前記DNA配列が該DNA配列の複製及び発現を指示可能な発現制御配列 と機能的に会合して構成される、請求の範囲第1項のDNA配列を用いてトラン スフォームされた細胞。 7.前記細胞が哺乳類又は細菌細胞である、請求の範囲第6項に記載の細胞。 8.適切な培養培地中で請求の範囲第6項の細胞を培養し、MCP−1Rタン パク質を前記細胞から単離することを含む、MCP−1Rタンパク質の作製方法 。 9.MCP−1レセプターのアンタゴニストを同定する方法であって、 a)MCP−1レセプターのN末端ドメインをコードする核酸配列を含む発 現ベクターを用いて哺乳類細胞株をトランスフェクトするステップと、 b)前記細胞株を培養培地で培養し、これにより前記レセプタードメインが 安定的に発現されるステップと、 c)前記レセプタードメインに対するMCP−1の結合を遮断するのに十分 な、有効量の有機化合物を前記培養培地に添加するステップと、 d)結合における前記損失を検出するステップと、 を含む、アンタゴニスト同定方法。 10.前記N末端ドメインが、他のMCP−1レセプター細胞外ドメインと結合 して発現される、請求の範囲第9項に記載の方法。 11.前記N末端ドメインが、天然MCP−1レセプターの一部として発現され る、請求の範囲第9項に記載の方法。 12.前記検出がイムノアッセイによる、請求の範囲第9項に記載の方法。 13.前記MCP−1が標識付けされる、請求の範囲第9項に記載の方法。 14.医薬的に許容可能なビヒクル中で請求の範囲9の方法を使用して同定され たMCP−1レセプターアンタゴニストの治療的有効量を含む、単球の浸潤によ って特徴付けられる疾患の治療に有用な医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18296294A | 1994-01-13 | 1994-01-13 | |
US08/182,962 | 1994-01-13 | ||
PCT/US1995/000476 WO1995019436A1 (en) | 1994-01-13 | 1995-01-11 | Mammalian monocyte chemoattractant protein receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09508264A true JPH09508264A (ja) | 1997-08-26 |
JP3532570B2 JP3532570B2 (ja) | 2004-05-31 |
Family
ID=22670813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51913395A Expired - Fee Related JP3532570B2 (ja) | 1994-01-13 | 1995-01-11 | 哺乳類単球化学誘引物質タンパク質レセプター |
Country Status (7)
Country | Link |
---|---|
US (6) | US6132987A (ja) |
EP (1) | EP0740701B1 (ja) |
JP (1) | JP3532570B2 (ja) |
AT (1) | ATE347594T1 (ja) |
AU (1) | AU1679395A (ja) |
DE (1) | DE69535327T2 (ja) |
WO (1) | WO1995019436A1 (ja) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE347594T1 (de) * | 1994-01-13 | 2006-12-15 | Univ California | Monocyten protein rezeptoren aus säugern, mit chemoattraktion auslösender wirkung |
US6537764B1 (en) * | 1995-01-19 | 2003-03-25 | Children's Medical Center Corporation | Method of identifying inhibitors of C—C chemokine receptor 3 |
GB9501683D0 (en) * | 1995-01-27 | 1995-03-15 | Glaxo Group Ltd | Substances and their uses |
US5776729A (en) * | 1995-06-05 | 1998-07-07 | Human Genome Sciences, Inc. | Human G-protein receptor HGBER32 |
US6743594B1 (en) * | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
US6025154A (en) * | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
AU2663295A (en) * | 1995-06-06 | 1996-12-24 | Human Genome Sciences, Inc. | Human g-protein chemokine receptor hdgnr10 |
US20040151719A1 (en) * | 1995-06-06 | 2004-08-05 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
EP1148126A3 (en) * | 1995-06-06 | 2003-12-03 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor HDGNR10 (CCR5 receptor) |
ATE428785T1 (de) | 1996-03-01 | 2009-05-15 | Euroscreen Sa | Aktive und inactive cc-chemokinrezeptoren und nukleinsäuremoleküle, die für diesen rezeptor kodieren |
SE9600820D0 (sv) * | 1996-03-01 | 1996-03-01 | Pharmacia Ab | Antibodies and their use |
DE69722491T2 (de) * | 1996-03-18 | 2004-05-19 | Kaneka Corp. | Adsorbens und Verfahren zur Entfernung von Chemokinen des CC-Subtyps aus Körperflüssigkeiten |
WO1997041225A2 (en) * | 1996-04-26 | 1997-11-06 | Incyte Pharmaceuticals, Inc. | Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr] |
US6011052A (en) * | 1996-04-30 | 2000-01-04 | Warner-Lambert Company | Pyrazolone derivatives as MCP-1 antagonists |
AU3375697A (en) | 1996-05-28 | 1998-01-05 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Cc chemokine receptor 5, antibodies thereto, transgenic animals |
US6673915B1 (en) | 1996-09-30 | 2004-01-06 | General Hospital Corporation | Nucleic acid encoding monocyte chemotactic protein 4 |
US5892014A (en) * | 1996-10-30 | 1999-04-06 | The Regents Of The University Of California | DNA encoding a protease-activated receptor 3 |
DE69834814D1 (de) | 1997-08-14 | 2006-07-20 | Us Gov Health & Human Serv | Verzögerter fortschritt von aids durch missense allel des ccr2 gens |
US6989435B2 (en) | 1997-09-11 | 2006-01-24 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US7067117B1 (en) | 1997-09-11 | 2006-06-27 | Cambridge University Technical Services, Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US6204024B1 (en) | 1997-09-12 | 2001-03-20 | Akzo Nobel N.V. | CCR5 RNA transcription based amplification assay |
WO1999047158A2 (en) | 1998-03-13 | 1999-09-23 | The University Of British Columbia | Therapeutic chemokine receptor antagonists |
CA2305787A1 (en) * | 2000-05-09 | 2001-11-09 | The University Of British Columbia | Cxcr4 antagonist treatment of hematopoietic cells |
CA2245224A1 (en) * | 1998-08-14 | 2000-02-14 | Jiang-Hong Giong | Chemokine receptor antagonists and chemotherapeutics |
US6287805B1 (en) * | 1998-03-20 | 2001-09-11 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules of the protein-coupled heptahelical receptor superfamily and uses therefor |
US6727349B1 (en) | 1998-07-23 | 2004-04-27 | Millennium Pharmaceuticals, Inc. | Recombinant anti-CCR2 antibodies and methods of use therefor |
US6696550B2 (en) | 1998-07-23 | 2004-02-24 | Millennium Pharmaceuticals, Inc. | Humanized anti-CCR2 antibodies and methods of use therefor |
US6312689B1 (en) * | 1998-07-23 | 2001-11-06 | Millennium Pharmaceuticals, Inc. | Anti-CCR2 antibodies and methods of use therefor |
EP1100963A2 (en) * | 1998-07-25 | 2001-05-23 | AstraZeneca AB | Human ccr-2 gene polymorphisms |
US7238711B1 (en) | 1999-03-17 | 2007-07-03 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US6911429B2 (en) * | 1999-04-01 | 2005-06-28 | Transition Therapeutics Inc. | Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
KR20030032916A (ko) * | 2000-02-09 | 2003-04-26 | 휴먼 게놈 사이언시즈, 인크. | Ccr5에 대한 항체 |
US7368425B2 (en) * | 2006-03-24 | 2008-05-06 | Chemokine Therapeutics Corp. | Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis |
US7378098B2 (en) * | 2000-04-12 | 2008-05-27 | The University Of British Columbia | CXC chemokine receptor 4 agonist peptides |
US20050059584A1 (en) * | 2002-08-16 | 2005-03-17 | Ahmed Merzouk | Novel chemokine mimetics synthesis and their use |
CA2335109A1 (en) * | 2000-04-12 | 2001-10-12 | Chemokine Therapeutics Corporation | Cxcr4 agonist treatment of hematopoietic cells |
US7625951B2 (en) * | 2000-07-13 | 2009-12-01 | University Of Kentucky Research Foundation | Stimuli-responsive hydrogel microdomes integrated with genetically engineered proteins for high-throughput screening of pharmaceuticals |
CA2437811A1 (en) | 2001-02-09 | 2002-08-22 | Human Genome Sciences, Inc. | Human g-protein chemokine receptor (ccr5) hdgnr10 |
US7175988B2 (en) * | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
US20040151721A1 (en) | 2001-10-19 | 2004-08-05 | O'keefe Theresa | Humanized anti-CCR2 antibodies and methods of use therefor |
US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
WO2005049799A2 (en) * | 2003-11-13 | 2005-06-02 | Bristol-Myers Squibb Company | Chimeric chemokine receptor polypeptides |
JP2007521248A (ja) | 2003-12-10 | 2007-08-02 | ミレニアム ファーマシューティカルズ, インコーポレイテッド | ヒト化抗ccr2抗体および該抗体を使用する方法 |
CA2559809A1 (en) * | 2004-03-12 | 2005-11-10 | Human Genome Sciences, Inc. | Antibodies against human g-protein chemokine receptor (ccr5) hdgnr10 |
WO2005101002A1 (en) * | 2004-04-13 | 2005-10-27 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 2 (ccr2) |
ES2333358T3 (es) * | 2005-04-15 | 2010-02-19 | Rappaport Family Institute For Research In The Medical Sciences | Moleculas y metodos de uso de las mismas para el tratamiento de enfermedades asociadas con mcp-1/ccr2. |
AU2007226155B2 (en) * | 2006-03-16 | 2014-04-03 | Protagonists Ltd. | Combination of cytokine and cytokine receptor for altering immune system functioning |
US7592156B2 (en) | 2006-07-20 | 2009-09-22 | Wyeth | Synthetic dog/human chimeric C-C chemokine receptor 2B |
PE20081785A1 (es) | 2007-02-19 | 2009-01-12 | Novartis Ag | Derivados de ciclohexil-amida del acido aril carboxilico |
US20080283557A1 (en) * | 2007-05-17 | 2008-11-20 | Julianne Desautels | Spout for food stuff container |
US20110038871A1 (en) | 2009-08-11 | 2011-02-17 | Veena Viswanth | Ccr2 inhibitors for treating conditions of the eye |
EP4252629A3 (en) | 2016-12-07 | 2023-12-27 | Biora Therapeutics, Inc. | Gastrointestinal tract detection methods, devices and systems |
EP3554541B1 (en) | 2016-12-14 | 2023-06-07 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
RU2676317C1 (ru) * | 2017-08-30 | 2018-12-27 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) | ГЕНЕТИЧЕСКАЯ КОНСТРУКЦИЯ pCXCRs-Fc ДЛЯ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО СЛИТОГО БЕЛКА, ОБЛАДАЮЩЕГО АНТИ-IL-8 АКТИВНОСТЬЮ |
KR20210095165A (ko) | 2018-11-19 | 2021-07-30 | 프로제너티, 인크. | 바이오의약품으로 질환을 치료하기 위한 방법 및 디바이스 |
CN115666704A (zh) | 2019-12-13 | 2023-01-31 | 比奥拉治疗股份有限公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5460955A (en) * | 1991-01-03 | 1995-10-24 | Wisconsin Alumni Research Foundation | Fibronectin purification vector |
WO1993019177A1 (en) * | 1992-03-18 | 1993-09-30 | The General Hospital Corporation | FOUR NOVEL RECEPTORS OF THE TGF-β RECEPTOR FAMILY |
US5413778A (en) * | 1992-10-05 | 1995-05-09 | The Regents Of The University Of Michigan | Labelled monocyte chemoattractant protein material and medical uses thereof |
US5459128A (en) * | 1993-11-12 | 1995-10-17 | Dana-Farber Cancer Institute | Human monocyte chemoattractant protein-1 (MCP-1) derivatives |
ATE347594T1 (de) | 1994-01-13 | 2006-12-15 | Univ California | Monocyten protein rezeptoren aus säugern, mit chemoattraktion auslösender wirkung |
US5776729A (en) * | 1995-06-05 | 1998-07-07 | Human Genome Sciences, Inc. | Human G-protein receptor HGBER32 |
SE9600820D0 (sv) * | 1996-03-01 | 1996-03-01 | Pharmacia Ab | Antibodies and their use |
US6723520B2 (en) * | 1996-07-05 | 2004-04-20 | Schering Corporation | Antibodies that bind chemokine teck |
DE69834814D1 (de) * | 1997-08-14 | 2006-07-20 | Us Gov Health & Human Serv | Verzögerter fortschritt von aids durch missense allel des ccr2 gens |
US6287805B1 (en) * | 1998-03-20 | 2001-09-11 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules of the protein-coupled heptahelical receptor superfamily and uses therefor |
US6312689B1 (en) * | 1998-07-23 | 2001-11-06 | Millennium Pharmaceuticals, Inc. | Anti-CCR2 antibodies and methods of use therefor |
AU2001250412A1 (en) * | 2000-03-31 | 2001-10-08 | Ipf Pharmaceuticals Gmbh | Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
US20020150877A1 (en) * | 2000-09-28 | 2002-10-17 | Meena Augustus | Cancer gene determination and therapeutic screening using signature gene sets |
WO2002061087A2 (en) * | 2000-12-19 | 2002-08-08 | Lifespan Biosciences, Inc. | Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides |
US20030188889A1 (en) | 2002-04-09 | 2003-10-09 | Ppc Electronic Ag | Printed circuit board and method for producing it |
-
1995
- 1995-01-11 AT AT95908495T patent/ATE347594T1/de active
- 1995-01-11 AU AU16793/95A patent/AU1679395A/en not_active Abandoned
- 1995-01-11 EP EP95908495A patent/EP0740701B1/en not_active Expired - Lifetime
- 1995-01-11 US US08/446,669 patent/US6132987A/en not_active Expired - Lifetime
- 1995-01-11 DE DE69535327T patent/DE69535327T2/de not_active Expired - Lifetime
- 1995-01-11 JP JP51913395A patent/JP3532570B2/ja not_active Expired - Fee Related
- 1995-01-11 WO PCT/US1995/000476 patent/WO1995019436A1/en active IP Right Grant
- 1995-05-25 US US08/450,393 patent/US5707815A/en not_active Expired - Lifetime
-
2000
- 2000-07-25 US US09/625,573 patent/US6730301B1/en not_active Expired - Fee Related
-
2004
- 2004-03-01 US US10/791,166 patent/US20040223968A1/en not_active Abandoned
- 2004-03-01 US US10/791,592 patent/US7105641B2/en not_active Expired - Fee Related
-
2007
- 2007-02-05 US US11/702,711 patent/US7803560B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6132987A (en) | 2000-10-17 |
US20040223968A1 (en) | 2004-11-11 |
JP3532570B2 (ja) | 2004-05-31 |
AU1679395A (en) | 1995-08-01 |
WO1995019436A1 (en) | 1995-07-20 |
US5707815A (en) | 1998-01-13 |
US7803560B2 (en) | 2010-09-28 |
US20090123938A1 (en) | 2009-05-14 |
DE69535327D1 (de) | 2007-01-18 |
US20040219644A1 (en) | 2004-11-04 |
EP0740701B1 (en) | 2006-12-06 |
EP0740701A1 (en) | 1996-11-06 |
US7105641B2 (en) | 2006-09-12 |
ATE347594T1 (de) | 2006-12-15 |
DE69535327T2 (de) | 2007-06-06 |
EP0740701A4 (en) | 1998-12-30 |
US6730301B1 (en) | 2004-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09508264A (ja) | 哺乳類単球化学誘引物質タンパク質レセプター | |
US5256766A (en) | Recombinant thrombin receptor and related pharmaceuticals | |
US20070248593A1 (en) | 32 Human Secreted Proteins | |
US7482442B2 (en) | HEMCM42 nucleic acids | |
KR20010033486A (ko) | 신규한 g 단백질 결합 수용체 | |
JP2006055164A (ja) | TGF−β型受容体cDNAおよびその用途 | |
US6461822B2 (en) | Methods of screening compounds for their ability to inhibit the production of inflammatory cytokines | |
JPH06506596A (ja) | インターロイキン−8受容体及び関連分子及び方法 | |
KR20010041418A (ko) | 프로테아제-활성화되는 수용체 4 및 그것의 사용 | |
EP0948323A1 (en) | Protease-activated receptor 3 and uses thereof | |
WO1996040040A2 (en) | Thrombin receptor homolog | |
JP2000083669A (ja) | Cxcr4ケモカイン受容体のヒトスプライス変異体cxcr4b | |
JP2000510690A (ja) | 哺乳類混合リンパ球受容体、ケモカイン受容体(mmlr―ccr) | |
JP2005507638A (ja) | ヒトgタンパク質共役型受容体93870およびその使用 | |
US20030092035A1 (en) | Pain signaling molecules | |
CA2066491C (en) | Human neurokinin-1 receptor | |
JP2002510054A (ja) | 薬剤スクリーニング標的用のトソ | |
US6258943B1 (en) | Human neurokinin-3 receptor | |
WO2001073026A2 (en) | 43238, a novel g protein-coupled receptor and uses therefor | |
JP2008519593A (ja) | ロイシンリッチリピート(lrr)モチーフ含有タンパク質 | |
JPH09176048A (ja) | ヒトMIP−1α/RANTES受容体タンパク質の製造法および用途 | |
WO2002031143A2 (en) | Nucleic acid sequences encoding cmg proteins cmg proteins and methods for their use | |
JPH06298799A (ja) | ヒトアンジオテンシンiiタイプ1レセプター、その製造法および用途 | |
JPH08103276A (ja) | 組換え型ヒト・インターロイキン8レセプター蛋白質、その製造法および用途 | |
JP2001520884A (ja) | ウイルスがコードするセマフォリンタンパク質受容体dnaおよびポリペプチド |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040224 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040304 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090312 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090312 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100312 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100312 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110312 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120312 Year of fee payment: 8 |
|
LAPS | Cancellation because of no payment of annual fees |